Related Experiment Video
Updated: Aug 10, 2026
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
Breaking the delivery barrier: magnetic nanoparticles at the Nexus of imaging and theranostics
Rajesh Singh1, Smita Jain2, Ashwini Kumar Mishra3
1Research and Development Laboratory, Ananta Medicare Ltd., Sri Ganganagar, Rajasthan 335002, India.
Abstract:
Cancer is still one of the major causes of death globally, and the lack of specificity of current chemotherapeutic and imaging agents still remains to be a major issue in the therapy of cancer, which lead to the lack of efficacy and high systemic toxicity. Magnetic nanoparticles (MNPs) especially Superparamagnetic Iron Oxide Nanoparticles (SPION) and Ultrasmall Superparamagnetic Iron Oxide Nanoparticles (USPION) have shown potential as theranostic platforms due to their magnetic responsiveness, biocompatibility, and multiple functionalities. The advantages of iron oxide-based nanomaterials such as Fe3O4 (magnetite) and maghemite (γ-Fe2O3) are that multiple imaging, targeting, hyperthermia and drug delivery modalities can be integrated into a single material, allowing for improved antitumoral efficacy while reducing off-target toxicity. The recent progress in the synthesis, surface modification of magnetic nanoparticles with biocompatible polymers and targeting ligands, and their physicochemical characterization, for optimization of biological performance, is summarised. Special attention is given to the strategies for targeted and controlled delivery such as magnetic field guided localization, stimuli responsive drug release, ligand mediated targeting, and multifunctional nanocarrier design. Additionally, recent advances in magnetic resonance imaging (MRI), image-guided therapy, multimodal therapy and clinically relevant theranostic applications are critically discussed. Current challenges in translation are also discussed, such as scale-up, long-term safety, regulatory aspects and clinical translation. In conclusion, the magnetic nanoplatforms based on SPIONs and USPIONs are a very promising approach to precision oncology, combining diagnostic, therapeutic and monitoring functions in a single nanoplatform, which will facilitate the translation of magnetic nanomedicine toward personalized cancer treatment.
Insights
Magnetic nanoparticles offer a promising theranostic platform for cancer treatment. These iron oxide-based nanomaterials enable targeted drug delivery and imaging, improving efficacy and reducing toxicity for personalized oncology.
Area of Science:
- Nanomedicine
- Oncology
- Materials Science
Background:
- Cancer remains a leading global cause of death, with current therapies suffering from poor specificity, leading to reduced efficacy and high systemic toxicity.
- Magnetic nanoparticles (MNPs), particularly Superparamagnetic Iron Oxide Nanoparticles (SPIONs) and Ultrasmall Superparamagnetic Iron Oxide Nanoparticles (USPIONs), present a novel theranostic approach.
- Iron oxide nanomaterials (e.g., Fe3O4, γ-Fe2O3) offer multifunctional capabilities for integrated imaging, targeting, hyperthermia, and drug delivery.
Purpose of the Study:
- To summarize recent advancements in the synthesis, surface modification, and characterization of magnetic nanoparticles for optimized biological performance in cancer therapy.
- To highlight strategies for targeted and controlled delivery, including magnetic field guidance, stimuli-responsive release, ligand-mediated targeting, and multifunctional nanocarrier design.
- To critically discuss recent progress in magnetic resonance imaging (MRI), image-guided therapy, multimodal therapy, and clinically relevant theranostic applications.
Main Methods:
- Review of recent literature on the synthesis and surface functionalization of SPIONs and USPIONs.
- Analysis of strategies for targeted drug delivery and controlled release mechanisms.
- Discussion of advancements in MRI, image-guided therapy, and multimodal therapeutic approaches.
Main Results:
- Magnetic nanoparticles can be engineered with biocompatible polymers and targeting ligands for enhanced biological performance.
- Various strategies enable targeted and controlled delivery of therapeutics, improving antitumoral efficacy while minimizing off-target effects.
- Significant progress has been made in integrating diagnostic and therapeutic functions into single nanoplatforms for theranostic applications.
Conclusions:
- Magnetic nanoplatforms based on SPIONs and USPIONs represent a highly promising avenue for precision oncology.
- These platforms integrate diagnostic, therapeutic, and monitoring functions, facilitating personalized cancer treatment.
- Further research addressing scale-up, long-term safety, and regulatory aspects is crucial for clinical translation.
